ZEPATIER 50 mg/1
elbasvir and grazoprevir · TABLET, FILM COATED · Merck Sharp & Dohme LLC
ZEPATIER is a tablet, film coated containing elbasvir and grazoprevir at 50 mg/1, taken oral. Manufactured by Merck Sharp & Dohme LLC.
Key Facts
- Brand Name
- ZEPATIER
- Generic Name
- elbasvir and grazoprevir
- NDC Code (Product)
0006-3074- Manufacturer
- Merck Sharp & Dohme LLC
- Strength
- 50 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA208261
- Drug Class
- Hepatitis C Virus NS5A Inhibitor [EPC]; Hepatitis C Virus NS3/4A Protease Inhibitor [EPC]
- Marketing Start
- 01/28/2016
Recall History
No Recall HistoryFrequently Asked Questions
What is ZEPATIER used for?
ZEPATIER contains elbasvir and grazoprevir. It is a tablet, film coated taken oral. Consult your doctor for specific uses.
Is ZEPATIER a controlled substance?
ZEPATIER is not classified as a controlled substance by the DEA.
What is the generic name for ZEPATIER?
The generic name for ZEPATIER is elbasvir and grazoprevir. There are no other listed brand versions of elbasvir and grazoprevir.
What is the NDC code for ZEPATIER 50 mg/1?
The NDC (National Drug Code) for ZEPATIER 50 mg/1 is 0006-3074, listed by Merck Sharp & Dohme LLC.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)